Literature DB >> 19797231

Oligocone trichromacy: clinical and molecular genetic investigations.

Mette K G Andersen1, Nynne L B Christoffersen, Birgit Sander, Carsten Edmund, Michael Larsen, Tanja Grau, Bernd Wissinger, Susanne Kohl, Thomas Rosenberg.   

Abstract

PURPOSE: To describe the phenotype and genotype of patients with a diagnosis of oligocone trichromacy (OT).
METHODS: Six unrelated patients had a detailed ophthalmic examination including color vision testing, a Goldmann visual field test, fundus photography, and full-field electroretinography (ffERG). Five patients also underwent multifocal (mf)ERG, autofluorescence recording, and optical coherence tomography (OCT). Genetic analysis included sequencing of all coding regions and flanking introns of CNGA3, CNGB3, GNAT2, KCNV2, and PDE6C.
RESULTS: All patients had subnormal visual acuity, a history of congenital nystagmus, and subjectively normal or near-normal color vision; five patients reported photophobia. Clinical examinations revealed largely normal fundi, normal Goldmann visual field results with the IV/4e target, and normal color discrimination or mild color vision deficiency. Electrophysiological investigations showed either complete absence of recordable cone responses or severely reduced amplitudes. All retinal layers were identifiable by OCT, which also showed thinning of the peripheral retina. Genetic analysis revealed two causative CNGB3 mutations in one patient and single heterozygous mutations of unknown significance in CNGB3 and PDE6C in two other patients.
CONCLUSIONS: Oligocone trichromacy is a heterogeneous condition with respect to both phenotypic appearance and genetic background. The finding of mutations in genes known to be involved in complete and incomplete achromatopsia supports the notion that some forms of OT is an extreme form of incomplete achromatopsia with preferential loss of peripheral cones.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797231     DOI: 10.1167/iovs.09-3988

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

Review 1.  [Achromatopsia].

Authors:  C M Poloschek; S Kohl
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

2.  CNGA3 deficiency affects cone synaptic terminal structure and function and leads to secondary rod dysfunction and degeneration.

Authors:  Jianhua Xu; Lynsie M Morris; Stylianos Michalakis; Martin Biel; Steven J Fliesler; David M Sherry; Xi-Qin Ding
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-01       Impact factor: 4.799

3.  Retinal structure in young patients aged 10 years or less with Best vitelliform macular dystrophy.

Authors:  Patrik Schatz; Dror Sharon; Sermed Al-Hamdani; Sten Andréasson; Michael Larsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-05       Impact factor: 3.117

4.  Long-term follow-up of two patients with oligocone trichromacy.

Authors:  Vasily Smirnov; Isabelle Drumare; Ikram Bouacha; Bernard Puech; Sabine Defoort-Dhellemmes
Journal:  Doc Ophthalmol       Date:  2015-07-03       Impact factor: 2.379

5.  Loss of cone cyclic nucleotide-gated channel leads to alterations in light response modulating system and cellular stress response pathways: a gene expression profiling study.

Authors:  Hongwei Ma; Arjun Thapa; Lynsie M Morris; Stylianos Michalakis; Martin Biel; Mark Barton Frank; Melissa Bebak; Xi-Qin Ding
Journal:  Hum Mol Genet       Date:  2013-06-04       Impact factor: 6.150

6.  Integrity of the cone photoreceptor mosaic in oligocone trichromacy.

Authors:  Michel Michaelides; Jungtae Rha; Elise W Dees; Rigmor C Baraas; Melissa L Wagner-Schuman; John D Mollon; Adam M Dubis; Mette K G Andersen; Thomas Rosenberg; Michael Larsen; Anthony T Moore; Joseph Carroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

7.  Dark-adaptation functions in molecularly confirmed achromatopsia and the implications for assessment in retinal therapy trials.

Authors:  Jonathan Aboshiha; Vy Luong; Jill Cowing; Adam M Dubis; James W Bainbridge; Robin R Ali; Andrew R Webster; Anthony T Moore; Frederick W Fitzke; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-28       Impact factor: 4.799

Review 8.  The cone dysfunction syndromes.

Authors:  Jonathan Aboshiha; Adam M Dubis; Joseph Carroll; Alison J Hardcastle; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2015-03-13       Impact factor: 4.638

9.  Molecular and clinical characterization of Thai patients with achromatopsia: identification of three novel disease-associated variants in the CNGA3 and CNGB3 genes.

Authors:  Worapoj Jinda; Aekkachai Tuekprakhon; Wanna Thongnoppakhun; Chanin Limwongse; Adisak Trinavarat; La-Ongsri Atchaneeyasakul
Journal:  Int Ophthalmol       Date:  2020-08-31       Impact factor: 2.031

10.  Retinal Architecture in ​RGS9- and ​R9AP-Associated Retinal Dysfunction (Bradyopsia).

Authors:  Rupert W Strauss; Adam M Dubis; Robert F Cooper; Rola Ba-Abbad; Anthony T Moore; Andrew R Webster; Alfredo Dubra; Joseph Carroll; Michel Michaelides
Journal:  Am J Ophthalmol       Date:  2015-09-03       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.